Home      |      Get Flash Player      |      Purchase CD-ROMs      |      Tech Support      |      Enter Drawing To Win Free Usage Required Plug-Ins Sort by Date/Session Title | Sort by Presentation Title | Sort by Speaker Name   Tuesday, February 19, 2008 Advanced Stroke Concepts and Transitional Care Challenges Clinical Localization of Stroke Anne Alexandrov - 1:15 PM (0h 58m 33s) - - View Understanding Mechanisms of Clinical Deterioration in Acute Cerebral Ischemia. Anne Alexandrov - 2:15 PM (0h 16m 16s) - - View Basics of Stroke Imaging and Diagnostics Deborah Summers - 2:30 PM (0h 53m 22s) - - View Reversal Methods for Antiplatelet and Anticoagulant Drugs in Patients with Hemorrhagic Strokes Janette Yanko - 3:45 PM (0h 16m 2s) - - View Robotic Telestroke Program: Transforming Stroke Care Delivery Connie Parliament - 4:45 PM (0h 23m 33s) - - View Current Issues in Community Reintegration Post-Stroke Depression: An Update Rosemarie King - 1:15 PM (0h 56m 36s) - - View Resiliency of Appalachian Women Who Survive Stroke: Measuring Comeback Patricia Vanhook - 2:15 PM (0h 16m 30s) - - View Matching Needs of Stroke Survivors to Caregiving Resources - What are the Issues and What Can We Do about Them? Barbara Lutz - 2:30 PM (0h 50m 50s) - - View Motivators for Exercise after Stroke Kathleen Michael - 3:45 PM (0h 17m 56s) - - View Caregiver Interventions in Research and Practice Tamilyn Bakas - 4:00 PM (0h 34m 3s) - - View Analysis of Risk Factors in Patients Receiving Carotid Artery Angioplasty and Stenting in A Multidisciplinary Carotid Disease Clinic Maureen Mathews - 4:45 PM (0h 15m 9s) - - View Essentials of Standard Practice and Stroke Center Development Neurological Assessment and NIHSS Training Diane Aubrey - 1:15 PM (0h 44m 14s) - - View Smoke-free Successes With The Ottawa Model: The Stroke Program Experience Sophia Gocan - 2:15 PM (0h 15m 50s) - - View Therapy in Acute Ischemic Stroke: Best Practices and Challenging Cases Steven Warach - 2:30 PM (0h 48m 51s) - - View Stroke Center Development and Certification Wende Fedder - 4:00 PM (0h 32m 28s) - - View The Self-management TO Prevent (STOP) Stroke Clinic: Teaching, Translational Research and Technology. Jane Anderson; Pamela Wilson - 4:45 PM (0h 18m 12s) - - View Plenary Session Opening Remarks Susan Pressler - 8:30 AM (0h 4m 49s) - - View Program Announcements Elaine Miller - 8:35 AM (0h 5m 36s) - - View Nursing: A Journey to Improving the Nation's Health Carol Romano - 8:40 AM (0h 45m 14s) - - View Update: 2007 Ischemic and Hemorrhage Stroke Guidelines Barbara Mancini - 9:30 AM (0h 28m 59s) - - View Blood Pressure Management Arthur Pancioli - 10:00 AM (0h 46m 44s) - - View Glucose Management Brett Kissela - 11:00 AM (0h 47m 44s) - - View   Wednesday, February 20, 2008 Acute Management Oral Abstracts I The Combined Approach To Lysis Utilizing Eptifibatide And rt-PA In Acute Ischemic Stroke (the CLEAR Stroke Trial): Final Results From Tier I and II Arthur Pancioli - 9:10 AM (0h 12m 51s) - - View Does Study Enrollment Delay Treatment with Intravenous Thrombolytics for Acute Ischemic Stroke? Sheryl Martin Schild - 9:22 AM (0h 9m 58s) - - View Lack of Adherence to Guidelines for Pre-TPA Blood Pressure Levels Is Associated with Higher Risk of Symptomatic Intracerebral Hemorrhage Georgios Tsivgoulis - 9:34 AM (0h 8m 3s) - - View Feasibility of Caffeinol and Hypothermia for Acute Ischemic Stroke Sheryl Martin-Schild - 9:46 AM (0h 13m 47s) - - View The Metabolic Syndrome is Associated with a Higher Resistance to i.v. Thrombolysis for Acute Ischemic Stroke in Women Than in Men Juan Arenillas - 9:58 AM (0h 13m 51s) - - View A Method to Predict Stroke Trial Success Based on Pooled Control Arms Thomas Kent; Pitchaiah Mandava - 10:10 AM (0h 15m 35s) - - View Influence of FXII 46C/T, FVII 401G/T -323 and FVII 670 A/C Polymorphisms on the Outcome and Risk of Cerebral Hemorrhage in Patients with Ischemic Stroke Treated with RT-PA Joan Martí-Fàbregas - 10:22 AM (0h 11m 54s) - - View Clinical Approaches to Brain Repair after Stroke Modulating specific neurotransmitter systems Steven Cramer - 7:30 AM (0h 20m 12s) - - View Task-Oriented Training Carolee Winstein - 7:50 AM (0h 18m 16s) - - View Electromagnetic brain stimulation Leonardo Cohen - 8:10 AM (0h 19m 55s) - - View Cellullar therapies Sean Savitz - 8:30 AM (0h 30m 20s) - - View Cognitive Implications of Mixed" Cerebrovascular and Alzheimer's Disease" Interactions between cerebral ischemia and beta-amyloid toxicity in a rodent model: Implications for mixed" AD and CVD" David Cechetto - 7:30 AM (0h 19m 55s) - - View Voxel-based morphometric differences between patients with amnestic MCI and Vascular CIND Glenn Stebbins - 7:50 AM (0h 17m 52s) - - View The Epidemiology of Mixed AD and Cerebrovascular Disease David Nyenhuis - 8:10 AM (0h 15m 31s) - - View Treatment Options for Patients with Mixed AD and Cerebrovascular Disease Sandra Black - 8:30 AM (0h 35m 32s) - - View Experimental Ischemia Oral Abstracts I Selective ETA Receptor Antagonism: Perfusion/Diffusion MRI Defines Treatment Efficacy, Mechanism and Translatable Stroke Model for SB 234551 Frank Barone - 9:10 AM (0h 11m 43s) - - View NADPH Oxidase from Circulating Inflammatory Cells Exacerbates Injury in Experimental Stroke Xian Tang - 9:22 AM (0h 12m 0s) - - View Mast Cells Are Early Responders After Hypoxia-ischemia In Immature Rat Brain Yuxuan Jin - 9:34 AM (0h 11m 38s) - - View Key Role of the Scavenger Receptor CD36 in Postischemic Inflammation and Ischemic Brain Injury Alexander Kunz - 9:46 AM (0h 11m 33s) - - View Timing Of MGE Cell Transplantation After Distal Middle Cerebral Artery Occlusion Significantly Influences The Cell-host Interaction Hideo Shichinohe - 10:10 AM (0h 13m 42s) - - View Resveratrol Preconditioning Induced Neuroprotection Is Mediated Via Sirt1-Uncoupling Protein 2 Pathway. David Della Morte - 10:22 AM (0h 10m 18s) - - View Giant Intracranial Aneurysm: A Difficult Challenge Microsurgery: Bypass and Other Adjuncts Robert Solomon - 9:10 AM (0h 14m 22s) - - View Endovascular Approaches Jacques Moret - 9:30 AM (0h 23m 24s) - - View Real Life: How Do We Choose? Microsurgery vs Endovascular Daniel Barrow - 9:50 AM (0h 19m 37s) - - View Real Life: How Do We Choose? Microsurgery vs Endovascular (Debate) Sean Lavine - 9:50 AM (0h 30m 31s) - - View Hemorrhage – Intracranial Aneurysm and Subarachnoid Hemorrhage Oral Abstracts Management of Unruptured Intracranial Aneurysm: Part 1 Natural History Yuichi Murayama - 2:00 PM (0h 11m 54s) - - View The Impact of Family History of Aneurysm or Subarachnoid Hemorrhage on Aneurysm Characteristics and Outcome: Results from the International Study of Unruptured Intracranial Aneurysms Robert Brown - 2:12 PM (0h 17m 11s) - - View Cost-effectiveness Analysis of Endovascular Treatment versus Neurosurgical Treatment for Ruptured Intracranial Aneurysms in the United States Alberto Maud - 2:24 PM (0h 9m 50s) - - View Long-term Follow-up Patients With Unruptured Intracranial Aneurysms James Torner - 2:36 PM (0h 14m 2s) - - View Under-Treatment and Outcomes of Non-Traumatic Subarachnoid Hemorrhage by Hospital Volume: A Multi-State Study Lucas Elijovich - 2:48 PM (0h 10m 22s) - - View Predictors of Retreatment of Ruptured Intracranial Aneurysms: The Cerebral Aneurysm Rupture After Treatment Study Chirag Patil - 3:00 PM (0h 14m 10s) - - View Unruptured Cerebral Aneurysms Presenting with Ischemic Events Nancy McLaughlin - 3:12 PM (0h 7m 30s) - - View Hemorrhage-Intraparenchymal Oral Abstracts Subgroup Analysis In the Fast Trial: A Subset of Intracerebral Hemorrhage Patients That Benefit from Recombinant Activated Factor VII? Stephan Mayer - 7:30 AM (0h 11m 36s) - - View Microbleeds Versus Macrobleeds: Evidence for Distinct Processes Steven Greenberg - 7:42 AM (0h 13m 26s) - - View Multicentre Prospective Study Demonstrates Feasibility Of CT-Angiography In Intracerebral Hemorrhage And Validity Of “Spot Sign” For Hematoma Expansion Prediction Andrew Demchuk - 7:54 AM (0h 10m 57s) - - View Polymorphisms in the Aquaporin 4 and Thrombin protease-activated receptors gene are related to Edema Volume In Patients With Acute Intracerebral Hemorrhage Yolanda Silva - 8:06 AM (0h 7m 4s) - - View Antiplatelet Medications and Hemorrhage Growth After Intracerebral Hemorrhage Lauren Sansing - 8:18 AM (0h 11m 22s) - - View In Vivo 11C PIB Binding is Increased in Patients with Cerebral Amyloid Angiopathy Haemorrhage John V Ly - 8:30 AM (0h 33m 6s) - - View How to Make Stroke Models Matter Quality control for modeling Ulrich Dirnagl - 7:30 AM (0h 16m 11s) - - View From in vitro to in vivo: models of cerebral ischemia Miguel Perez-Pinzon - 7:45 AM (0h 14m 52s) - - View Role of gender in animal and cell models of stroke Patricia Hurn - 8:00 AM (0h 14m 1s) - - View Physiologic control and hyperglycemia in stroke models Thomas Kent - 8:15 AM (0h 15m 9s) - - View Genes, species and translation Richard Traystman - 8:30 AM (0h 31m 13s) - - View In-Hospital Treatment Oral Abstracts Blood Pressure in Acute Stroke is Inversely Related to the Extent of Collaterals David Liebeskind - 4:00 PM (0h 13m 27s) - - View Outcomes of Moderate Hypothermia for Survivors of In-Hospital and Out-of-Hospital Cardiac Arrest Richard Bernstein - 4:12 PM (0h 13m 27s) - - View Slow Initiation of Care and Poor Outcomes for Patients Having In Hospital Ischemic Strokes Frank Silver - 4:24 PM (0h 14m 12s) - - View Stroke Response Nurses - Success in Ischemic Stroke Treatment Parallels Increase in Utilization Eight Years' Experience with 24/7 Stroke Response Nurses John Cochran - 4:36 PM (0h 13m 27s) - - View Impact of Dedicated Stroke Response System on In-Hospital Assessment and Outcomes of Patients with Acute Ischemic Stroke Gustavo Rodriguez - 4:48 PM (0h 9m 37s) - - View A Simplified Model for the Assessment of Quality of Stroke Care in Emerging Countries. The Argentinian National Stroke Registry (ReNACer). Luciano Sposato - 5:00 PM (0h 14m 33s) - - View Intravenous Tissue Plasminogen Activator Use Has a Low Risk of Neurosurgical Intervention Aslam Khaja - 5:12 PM (0h 15m 9s) - - View Interactive Stroke Research Amyloid-ischemia Interactions: Experimental Shawn Whitehead - 4:00 PM (0h 17m 34s) - - View Amyloid-ischemia Interactions: Clinical Eric Smith - 4:20 PM (0h 27m 51s) - - View Normotensive Hyperoxia: Experimental Eng Lo - 4:40 PM (0h 13m 0s) - - View Normotensive Hyperoxia: Clinical Marc Fisher - 5:00 PM (0h 32m 0s) - - View Intracranial Aneurysms: Current State-of-the-Art Microsurgery-The Refinement of Surgical Adjuncts Arthur Day - 7:30 AM (0h 21m 40s) - - View Endovascular Frontiers: What's Next? Michel Mawad - 7:50 AM (0h 22m 12s) - - View Real Life: How Do We Choose? Microsurgery vs Endovascular (Debate) Juha Hernesniemi - 8:10 AM (0h 44m 32s) - - View Real Life: How Do We Choose? Microsurgery vs Endovascular (Debate) Fredric Meyer - 8:10 AM (0h 44m 32s) - - View Intracranial Occlusive Disease Wingspan Stent Registry and Retrospective Data Elad Levy - 2:20 PM (0h 16m 31s) - - View Proposed Intracranial Stent Trial Design Peter Rasmussen - 2:40 PM (0h 18m 20s) - - View Moya Moya Gary Steinberg; B Gregory Thompson - 3:00 PM (0h 32m 20s) - - View Intracranial Occlusive Disease Oral Abstracts C-reactive Protein Gene C1444T Polymorphism Is Associated With An Increased Risk Of Further Ischemic Events In Patients With Symptomatic Intracranial Atherostenoses Juan Arenillas - 4:00 PM (0h 10m 17s) - - View Relationship of Site Experience with Clinical Outcomes in Patients Undergoing Intracranial Stenting in the NIH Multicenter Wingspan Registry Fadi Nahab - 4:12 PM (0h 12m 33s) - - View Analysis of Recurrent Ischemic Events Following Successful Therapy with the Wingspan System Babu Welch - 4:24 PM (0h 16m 55s) - - View Safety and Efficacy of Endovascular Thrombectomy in Patients with Abnormal Hemostasis: Pooled Analysis of the MERCI and Multi MERCI Trials Raul Nogueira - 4:36 PM (0h 11m 39s) - - View US Multi-Center Experience with the Wingspan Stent System for the Treatment of Intracranial Atheromatous Disease: Periprocedural Results for 156 patients Peter Rasmussen - 4:48 PM (0h 12m 21s) - - View Natural History of Asymptomatic Restenosis following Endovascular Treatment of Symptomatic Intracranial Stenosis Does Not Support Retreatment. Haitham Hussein - 5:00 PM (0h 9m 28s) - - View Treatment of Moyamoya Disease in the Adult Population with Indirect Cerebral Revascularization Utilizing Pial Synangiosis. Edward Smith - 5:12 PM (0h 14m 53s) - - View New (and Some Old) Targets for Acute Intervention: From Science to the Clinic Immunomodulation for stroke prevention John Hallenbeck - 4:00 PM (0h 20m 49s) - - View Foundation for Intra-arterial Stroke Therapy Using Plasmin, a Direct-acting Thrombolytic Agent Victor Marder - 4:20 PM (0h 16m 56s) - - View Modulating Endothelial Cell Anticoagulant Properties: Clinical Trials in Waiting Mark Fisher - 5:00 PM (0h 27m 50s) - - View Outcomes Oral Abstracts Long-Term Prognosis After Transient Ischemic Attack (TIA) Anthony Kim - 9:10 AM (0h 13m 1s) - - View Low-Income, Low-hospital Volume And High Stroke Mortality: The Puzzling Route Of Inequity Gustavo Saposnik - 9:22 AM (0h 12m 36s) - - View Does Stroke Patients Weight Influence The Response To Intravenous t-PA? Min Lou - 9:34 AM (0h 11m 26s) - - View Chronic Kidney Disease is a Strong Independent Predictor of Poor Outcome in Patients With Acute Stroke David Tanne - 9:46 AM (0h 13m 4s) - - View The Impact of Case Managed Care in Patients with Acute Stroke and Transient Ischemic Attack Annette Robertson - 9:58 AM (0h 11m 42s) - - View Long-term Use of Secondary Stroke Prevention Therapies among US Veterans Deborah Levine - 10:10 AM (0h 12m 19s) - - View Randomized Controlled Trial of a Post-stroke Post-discharge Care Management Intervention Kyle Allen - 10:22 AM (0h 11m 20s) - - View Ovarian Hormones, Pregnancy and Stroke: Risks, Management and Prevention Risks and Management of Ischemic Stroke During Pregnancy Steven Kittner - 2:00 PM (0h 18m 39s) - - View Risks and Management Strategies for Vascular Anomalies During Pregnancy Issam Awad - 2:20 PM (0h 18m 30s) - - View Preeclampsia/Eclampsia: Understanding the Pathophysiology of Cerebrovascular Complications Cheryl Bushnell - 2:40 PM (0h 22m 3s) - - View Plenary Symposium I: Blood to Save Brain: Endothelial Precursors, Stem Cells and Angiogenesis for Brain Repair Circulating endothelial precursors and therapeutic angiogenesis Zvonimir Katusic - 12:00 PM (0h 13m 1s) - - View Integrated responses in neurovasculogenesis after stroke. S. Thomas Carmichael - 12:15 PM (0h 14m 31s) - - View Functional or dysfunctional angiogenesis in acute stroke? Partick Lyden - 12:30 PM (0h 13m 24s) - - View Rehabilitation Intervention Effectiveness: Impact of Dose-response and Timing Post-stroke Dose issues related to the specificity and intensity of rehabilitation interventions: Evidence for overtraining effects Katherine Sullivan - 2:00 PM (0h 17m 14s) - - View Dose limits during the acute post-stroke phase Alexander Dromerick - 2:15 PM (0h 17m 39s) - - View Optimizing the scheduling and type of exercise to maximize functional outcomes Carolynn Patten - 2:30 PM (0h 17m 37s) - - View The effect of dose monitoring within a clinical trial Julie Bernhardt - 2:45 PM (0h 33m 4s) - - View Reversing Ischemia and Restraining Hemorrhage: Vascular Endpoints in Acute Stroke Trials Recanalization, Reperfusion, Hemorrhage and Infarct Evolution David Liebeskind - 2:05 PM (0h 22m 28s) - - View Angiographic Measures in Endovascular Thrombolysis and Thrombectomy Trials Thomas Tomsick - 2:26 PM (0h 24m 27s) - - View Imaging and Clinical Outcomes in Stroke: Match or Mismatch? Amie Hsia - 2:47 PM (0h 17m 37s) - - View Linking Surrogate and Clinical Outcomes From Early Hours to Day 90 Karen Johnston; Linda Williams - 3:08 PM (0h 15m 26s) - - View Stroke in Sickle Cell Disease: Recent Successes and On-going Challenges Changing Demographics of Stroke in Sickle Cell Disease Heather Fullerton - 9:10 AM (0h 16m 57s) - - View The STOP Trials: Lessons Learned and On-going Challenges Robert Adams - 9:30 AM (0h 22m 9s) - - View Small Vessel Stroke in Sickle Cell Disease: the Next Big Challenge Michael DeBaun - 9:50 AM (0h 21m 30s) - - View Genetic Predictors of Stroke in Sickle Cell Disease: How Can they Help Us? James Meschia - 10:10 AM (0h 26m 9s) - - View Update on Cerebral Hemorrhage Trials Acute blood pressure management - the North American perspective: Insights from the ATACH trial Adnan Qureshi - 4:00 PM (0h 20m 11s) - - View Acute blood pressure management - the Australasian perspective: Insights from the INTERACT study Craig Anderson - 4:20 PM (0h 19m 45s) - - View Intraventricular hemorrhage: A report from the CLEAR-IVH trial Issam Awad - 4:40 PM (0h 14m 54s) - - View Minimally invasive sterotactic thrombolysis: A report from the MISTIE trial. Daniel Hanley - 5:00 PM (0h 26m 58s) - - View   Thursday, February 21, 2008 Community/Risk Factors Oral Abstracts Insulin Resistance and Risk of Ischemic Stroke among Non-Diabetic Individuals from the Northern Manhattan Study Tatjana Rundek - 2:00 PM (0h 14m 31s) - - View C-Reactive Protein Predicts Recurrent Stroke and Death in a Hyperhomocyst(e)inemic Population Karen Furie - 2:12 PM (0h 11m 57s) - - View Daytime Sleepiness and Risk of Stroke and Vascular Disease: Findings from the Northern Manhattan Study (NOMAS) Bernadette Boden-Albala - 2:24 PM (0h 16m 4s) - - View Stroke in Women - Gender Differences in Stroke Incidence and Post-stroke Disability in the Framingham Heart Study Rodica Petrea - 2:36 PM (0h 12m 51s) - - View National Utilization of, and Outcomes following, Craniectomy for Space Occupying Cerebral Infarction in the United States. Mustapha Ezzeddine - 2:48 PM (0h 12m 48s) - - View Gene Variants Previously Associated With Coronary Heart Disease: Association With Incident Ischemic Stroke in the Cardiovascular Health Study May Luke - 3:00 PM (0h 13m 33s) - - View Analysis of the Age-at-Onset Phenotype in a Pilot Genome-Wide Association Study of Ischemic Stroke Bradford Worrall - 3:12 PM (0h 11m 59s) - - View Cost-effectiveness Studies in Stroke Projected cost of stroke Devin Brown - 7:30 AM (0h 14m 36s) - - View How to incorporate cost-effectiveness analysis in clinical trials David Matchar - 7:45 AM (0h 17m 43s) - - View Pharmacoeconomics of Stroke Treatment Susan Fagan - 8:00 AM (0h 20m 54s) - - View How to interpret cost effectiveness data in clinical practice Robert Holloway - 8:15 AM (0h 34m 28s) - - View Cranial and Spinal Vascular Malformations Oral Abstracts Natural History of Dural Arteriovenous Shunts Tommy Andersson - 4:00 PM (0h 12m 44s) - - View Benign Course of Borden Type 2 and 3 Dural Arteriovenous Fistulas Presenting Without Neurological Symptoms James Botros - 4:12 PM (0h 9m 11s) - - View Multimodality Care of Occipital Lobe AVMs: Neurological Outcomes of A Prospective Series of 134 Patients. Amir R. Dehdashti - 4:24 PM (0h 13m 19s) - - View Brainstem Arteriovenous Malformations: Natural History, Multimodality Management And Long Term Follow-up Laurent Thines - 4:36 PM (0h 15m 58s) - - View Plasma Levels of Matrix Metalloproteinases after Treatment for Cerebral Arteriovenous Malformations Robert Starke - 4:48 PM (0h 12m 52s) - - View Inflammatory Cell Infiltration in Cerebral Cavernous Malformations and Lesion Phenotype and Clinical Manifestations Robert Shenkar - 5:00 PM (0h 9m 58s) - - View Transforming Growth Factor-beta1 Polymorphisms and Risk of Intracranial Hemorrhage in Brain Arteriovenous Malformation Patients Helen Kim - 5:12 PM (0h 11m 26s) -